New Role of Tumor Mutation Burden as a Predictor to Chemo/Targeted Therapy in Advanced Non-Small Cell Lung Cancer

培美曲塞 医学 肺癌 肿瘤科 内科学 队列 癌症 化疗 靶向治疗 顺铂
作者
Lin Chen,Xun Shi,Jun Zhao,Qiong He,Yang Shao,Xinmin Yu,Ying Jin
出处
期刊:Social Science Research Network [Social Science Electronic Publishing]
标识
DOI:10.2139/ssrn.3463249
摘要

Background: Accumulating evidence illustrates greater benefit of immunotherapy in tumors with high-TMB, whereas its impact on response to targeted therapy or chemotherapy is undefined.Methods: In this retrospective study, we investigated the correlation of tumor mutation burden (TMB) and progression-free survival (PFS) of NSCLC patients who received EGFR-TKIs or Pemetrexed/Platinum as first line therapy. TMB was evaluated by targeted next generation sequencing (tNGS). Patients were divided into low(L) / intermediate(I) / high(H) TMB groups by tertiles.Results: In EGFR-mutant cohort, TMB-L patients had an massively improved PFS compared to TMB-I/H patients(P=0.006) when treated with first generation of EGFR-TKIs. In EGFR/ALK wild-type cohort who received Pemetrexed/Platinum regimen, the ORR in TMB-L group was statistically superior than that of TMB-I/H groups (P=0.037), and patients with low TMB had a numerically, but not significantly prolonged PFS (P=0.22). No difference in PFS was observed between TMB-I and TMB-H groups in two treatment arms.Conclusions: Low nonsynonymous TMB indicated a favorable PFS for EGFR-TKIs and positive response to Pemetrexed/Platinum in certain cohorts with advanced NSCLC, which could potentially identify patients more suitable for targeted therapy or chemotherapy, rather than immunotherapy.Funding Statement: This work was supported by National Natural Science Foundation of China (Grant No.81702248) and Zhejiang medical and health science and technology project (Grant No.2018KY309).Declaration of Interests: The authors have declared no conflicts of interest.Ethics Approval Statement: Study protocols were approved by the Ethical Review Community of Zhejiang Cancer Hospital. The requirement of informed consent was waived by the committee as it was a retrospective research.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hailee发布了新的文献求助10
1秒前
华仔应助脑瓜子嗡嗡滴采纳,获得10
1秒前
闪闪寄凡发布了新的文献求助10
1秒前
莉123发布了新的文献求助10
1秒前
3秒前
3秒前
诚心爆米花完成签到,获得积分10
4秒前
5秒前
5秒前
6秒前
dhhaoyihong完成签到,获得积分10
6秒前
小乖发布了新的文献求助10
6秒前
7秒前
简单的银耳汤完成签到,获得积分10
7秒前
7秒前
哈哈完成签到,获得积分10
8秒前
zhangpp完成签到,获得积分10
9秒前
10秒前
10秒前
10秒前
11秒前
香蕉觅云应助学习通采纳,获得10
11秒前
13秒前
inousCho完成签到,获得积分10
14秒前
33发布了新的文献求助10
15秒前
勤劳的老九应助zhangpp采纳,获得10
15秒前
郭老师发布了新的文献求助10
15秒前
15秒前
15秒前
16秒前
Lucas应助小乖采纳,获得10
17秒前
Jasper应助FunHigh采纳,获得10
17秒前
17秒前
深情安青应助xcy采纳,获得10
18秒前
orange完成签到,获得积分10
18秒前
翁雁丝发布了新的文献求助10
19秒前
20秒前
成功应助宇文天思采纳,获得10
20秒前
wIe完成签到,获得积分20
20秒前
宋宋发布了新的文献求助10
21秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975814
求助须知:如何正确求助?哪些是违规求助? 3520123
关于积分的说明 11201020
捐赠科研通 3256502
什么是DOI,文献DOI怎么找? 1798347
邀请新用户注册赠送积分活动 877523
科研通“疑难数据库(出版商)”最低求助积分说明 806417